QA: Tongli Pharmaceuticals USA Inc in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001052284_2013_Tongli_Pharmaceuticals_USA_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001052284, Tongli Pharmaceuticals USA Inc

  xvar xval
0 AssetsCurrent 9,137,391
1 IntangibleAssetsNetIncludingGoodwill 4,041,032
2 PropertyPlantAndEquipmentNet 6,193,526
3 remainder_Assets 469,726
4 LiabilitiesCurrent 1,500,843
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,724,711
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 11,586,467
11 remainder_Revenues 15,487,083
12 remainder_NetIncome -24,133
13 remainder_ComprehensiveNetIncome 371,822
  yvar yval
0 Assets 19,841,675
1 Liabilities 1,500,843
2 Expenses 13,311,178
3 Revenues 15,487,083
4 StockholdersEquity 18,340,832
5 NetIncome 2,151,772
6 ComprehensiveNetIncome 2,337,683
7 BaseVar 25,268,367
8 EconomicCapitalRatiobeforeLimitedLiability 3.97
9 EconomicCapitalRatio 4.37

Edgar->Model Mapping

Feature Distribution

Change over Time